These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6092715)

  • 21. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
    van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
    J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
    Spriggs MK; Collins PL; Tierney E; London WT; Murphy BR
    J Virol; 1988 Apr; 62(4):1293-6. PubMed ID: 2831389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.
    Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of parainfluenza virus infection in children and older patients by detection of specific IgM antibody.
    van der Logt JT; van Loon AM; Heessen FW; van der Veen J
    J Med Virol; 1985 Jun; 16(2):191-9. PubMed ID: 2989421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Components of parainfluenza-3 virus, SLP-strain, reacting in assays of cell-mediated immunity in cattle.
    Höglund S; Moreno-López J; Morein B
    Arch Virol; 1977; 53(4):323-33. PubMed ID: 194552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution to the study of the parainfluenza antigens.
    Bosshard S; Aymard M; Kessler N
    Dev Biol Stand; 1975; 28():18-27. PubMed ID: 165116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parainfluenza virus immunization. IV. Simultaneous immunization with parainfluenza types 1, 2, and 3 aqueous vaccines.
    Fulginiti VA; Amer J; Eller JJ; Joyner JW; Askin P
    Am J Dis Child; 1967 Jul; 114(1):26-8. PubMed ID: 4378106
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3.
    Du RP; Jackson GE; Wyde PR; Yan WY; Wang Q; Gisonni L; Sanhueza SE; Klein MH; Ewasyshyn ME
    Biotechnology (N Y); 1994 Aug; 12(8):813-8. PubMed ID: 7765021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.
    Yao Q; Hu X; Compans RW
    J Virol; 1997 Jan; 71(1):650-6. PubMed ID: 8985396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
    Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice.
    Morein B; Sharp M; Sundquist B; Simons K
    J Gen Virol; 1983 Jul; 64 (Pt 7)():1557-69. PubMed ID: 6306152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein.
    Elango N; Coligan JE; Jambou RC; Venkatesan S
    J Virol; 1986 Feb; 57(2):481-9. PubMed ID: 3003381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3.
    Tao T; Davoodi F; Cho CJ; Skiadopoulos MH; Durbin AP; Collins PL; Murphy BR
    Vaccine; 2000 Jan; 18(14):1359-66. PubMed ID: 10618533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.
    Ray R; Glaze BJ; Moldoveanu Z; Compans RW
    J Infect Dis; 1988 Apr; 157(4):648-54. PubMed ID: 2831281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.
    Orvell C; Kristensson K
    Arch Virol; 1985; 86(1-2):1-15. PubMed ID: 2994598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus.
    van Wyke Coelingh KL; Murphy BR; Collins PL; Lebacq-Verheyden AM; Battey JF
    Virology; 1987 Oct; 160(2):465-72. PubMed ID: 2821684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microencapsulated human parainfluenza virus induces a protective immune response.
    Ray R; Novak M; Duncan JD; Matsuoka Y; Compans RW
    J Infect Dis; 1993 Mar; 167(3):752-5. PubMed ID: 8382726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.